According to Rigel Pharmaceuticals's latest financial reports the company's total assets are NZ$0.25 Billion. A companyโs total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
Year | Total assets | Change |
---|---|---|
2023-12-31 | NZ$0.18 B | -12.36% |
2022-12-31 | NZ$0.21 B | -13.67% |
2021-12-31 | NZ$0.24 B | 60.14% |
2020-12-31 | NZ$0.15 B | -30.18% |
2019-12-31 | NZ$0.21 B | 5.66% |
2018-12-31 | NZ$0.20 B | 23.65% |
2017-12-31 | NZ$0.16 B | 48.69% |
2016-12-31 | NZ$0.11 B | -41.4% |
2015-12-31 | NZ$0.19 B | -2.15% |
2014-12-31 | NZ$0.19 B | -28.49% |
2013-12-31 | NZ$0.27 B | -27.01% |
2012-12-31 | NZ$0.37 B | 14.41% |
2011-12-31 | NZ$0.32 B | 36.13% |
2010-12-31 | NZ$0.24 B | 24.88% |
2009-12-31 | NZ$0.19 B | -21.83% |
2008-12-31 | NZ$0.24 B | 63.99% |
2007-12-31 | NZ$0.15 B | -5.96% |
2006-12-31 | NZ$0.16 B | -25.6% |
2005-12-31 | NZ$0.21 B | 95.58% |
2004-12-31 | NZ$0.11 B | 29.33% |
2003-12-31 | NZ$85.41 M | 0.81% |
2002-12-31 | NZ$84.72 M | -24.25% |
2001-12-31 | NZ$0.11 B |